title: Comment on the use of computational models to study the effect of apixaban and rivaroxaban on thrombin generation.
authors.affiliation: Romy Kremers, Oxfordlaan 70, 6229 EV, Maastricht, the Netherlands, Tel.: +31 43 388 5893, Fax: +31 43 388 4570, E-mail: r.kremers@thrombin.com.
authors.forename: Romy M W
authors.initials: RM
authors.lastname: Kremers
authors.forename: Rob J
authors.initials: RJ
authors.lastname: Wagenvoord
authors.forename: H Coenraad
authors.initials: HC
authors.lastname: Hemker
mesh_terms: D001777:Blood Coagulation / Q000187:drug effects*; D065427:Factor Xa Inhibitors / Q000494:pharmacology*; D006801:Humans; D011720:Pyrazoles / Q000494:pharmacology*; D011728:Pyridones / Q000494:pharmacology*; D000069552:Rivaroxaban / Q000494:pharmacology*
chemical_list: D065427:Factor Xa Inhibitors; D011720:Pyrazoles; D011728:Pyridones; D000069552:Rivaroxaban